Search form

Sections

University of Minnesota

The Markingson Files: University of Minnesota under new scrutiny in drug trial death

Dan Markingson suffered from schizophrenia and killed himself in May 2004 while taking part in a clinical trial for an antipsychotic drug made by AstraZeneca. The evolving case continues to highlight problems of research oversight at the university and state levels.

Know Your Source: Where Do Health Data Originate?

Over a series of posts, I’m going to try to break down some of the broad categories of data, discuss how they are used and point out some of their limitations. I’m going to cover four main areas: vital statistics, censuses, surveys, and estimates.

Q&A with Leigh Turner, Part 3: Celltex Tries to Intimidate a Whistleblower

Bioethicist Leigh Turner describes how the stem cell company Celltex tried to intimidate him and his university when he asked the FDA to investigate the company.

Q&A with Leigh Turner, Part 2: Finding Ethical Quandaries Amid Academic Rivalries

Bioethicist Leigh Turner talks about why he sicced the FDA on Celltex and about academic rivalries in the world of bioethics.

Q&A with Leigh Turner: Tracking Medical Tourism Consequences

Bioethicist Leigh Turner, recently under fire from a stem cell company he criticized for ethical problems, talks about his research on medical tourism.

Slap: Celltex Threatens University of Minnesota For Ethicist's FDA Letter

When controversial bioethicist Glenn McGee quit his job as chief ethics advisor to Houston-based Celltex Therapeutics in February, the controversy over the company was on the verge of dying down. Until Celltex threatened a major public university and the very concept of free speech.

The Markingson Files: Court leaves key questions in clinical trial suicide unanswered

Any investigative reporter will tell you that a case dismissal does not necessarily mean a victory. Here's how that rule of thumb figures into the case of Dan Markingson, who committed suicide after participating in a clinical trial for the psychiatric drug Seroquel.

The Markingson Files: University of Minnesota dallies on clinical trial documentation

A candid email from a university publicist sheds some, but not enough, light on why the university won't provide documents from a controversial Seroquel clinical study.

New FCC Journalism Report Paints Bleak Picture of Health Coverage

The long-awaited Federal Communications Commission report on American journalism, Information Needs of Communities, paints a poignant picture of the decline of health journalism at the nation’s newspapers.

The Markingson Files: Conflicts of interest in clinical trials should be transparent

It can be uncomfortable asking people about their finances. In journalism, though, there is an obligation not only to ask, but to ask for proof — especially with clinical trials.

Pages

Announcements

Since the passage of the ACA, hospital consolidation has dramatically increased. Our webinar will give an overview of this trend, clarify what’s at stake for consumers, and give journalists fresh ideas for reporting in new, incisive ways. Our panel will include experts Martin Gaynor and Paul Ginsburg, as well as NYT’s Margot Sanger-Katz. More info here.

CONNECT WITH THE COMMUNITY

Member Activities

Kathleen O'Brien has shared a blog post

Read it.

Ada Calhoun joined the community

Connect with Ada Calhoun

William Heisel has shared a blog post

Read it.

SE Ruckman's profile has been updated

Connect with SE Ruckman

Sally James's profile has been updated

Connect with Sally James
More Member Activities

Follow Us

ReportingHealth

Reporting on Underserved Communities



How can journalists and foundations collaborate to deepen and improve reporting on underserved communities? Our USC Annenberg School of Journalism program in collaboration with The California Endowment, the Wyncote Foundation and Media Impact Funders, convened 75 leaders from both fields.

Read More »